During Market hours yesterday — Monday (28.12.2020):
Stocks jumped to record highs on Monday to start the final trading week of 2020 after President Donald Trump signed an economic relief bill.
- The Dow (Symbol: DIA) closed higher by 0.6%. The S&P 500 (Symbol: SPY) rose 0.8%. The Nasdaq (Symbol: QQQ) went up 1%.
- Nikola (Symbol: NKLA) — Shares of the electric-vehicle maker rose more than 19% after a JPMorgan analyst said he sees a “less drama-filled” news flow for the company in 2021. “We expect Nikola to post a video of a functioning Tre in January. We look for a steady flow of updates for the truck in 2021, as test milestones are met,” the analyst said.
- Myovant Sciences (Symbol: MYOV) — Shares rose 20% after the company agreed to a collaboration with Pfizer to develop prostate cancer drug relugolix. The drug is also being explored for possible use in women’s health.
- Weibo (Symbol: WB) — The stock dropped more than 13% despite a better-than-expected quarterly report from the Chinese social media company. Weibo posted adjusted profit of 66 cents per share, 6 cents above Refinitiv estimates. Its revenue also came in above analyst forecasts. Some analysts flagged the slowdown in the company’s growth in average active daily users, however.
- Astrazeneca (Symbol: AZN) — U.S.-listed shares of the drug maker gained more than 1.5% after multiple reports said that the company’s Covid vaccine, which was developed in partnership with Oxford University, is expected to be approved in the U.K. this week. The AstraZeneca shot would likely be rolled out next week if approved in the next few days.
- Apple (Symbol: AAPL) — Shares of the tech giant advanced more than 3.5% amid strength in Big Tech. The advance comes after Apple posted its fourth straight week of gains.
- Novavax (Symbol: NVAX) — Shares dipped more than 9.5% after the biotechnology company said its coronavirus vaccine candidate entered a Phase 3 trial in the U.S. and Mexico. “This trial is a critical step in building the global portfolio of safe and effective vaccines to protect the world’s population,” said CEO Stanley Erck in a statement.
- DoorDash (Symbol: DASH) — The food delivery company fell 6.67% after a Wall Street Journal column highlighted how a new bill in California could hurt delivery services. The regulation would require businesses to have stated agreements with restaurants, potentially hurting the growth strategy for some services.
During Premarket hours today – Tuesday (29.12.2020):
- Boeing (Symbol: BA) – Boeing is on watch today as American Airlines becomes the first U.S. carrier to return the updated 737 Max jet to service, with a flight from Miami to New York’s LaGuardia Airport. Boeing stock was up 1.5% at around 7:45 a.m. ET.
- Barnes & Noble Education (Symbol: BNED) – The college campus bookstore chain plans to continue recent cost cutting efforts in anticipation of another semester of remote learning. The company’s stock was up nearly 13% at around 7:45 a.m. ET.
- Alibaba (Symbol: BABA) – The China-based e-commerce company remains on watch, after recovering from last Thursday’s 13.3% drop with a very slight gain Monday. Alibaba shares gained 3% as of 7:45 a.m. ET.
- Lemonade (Symbol: LMND) – About 44 million shares of the online insurance company will become eligible for sale today. The stock has fallen sharply over the past two trading days in anticipation, losing about 7% last Thursday and another 14% yesterday. As of 7:45 a.m. ET, the stock had shed another 4.5%.
- Arcturus Therapeutics (Symbol: ARCT) – The San Diego-based biotech company’s shares plunged more than 35% in premarket trading, following the release of data regarding its Covid-19 vaccine candidate. That comes despite what Arcturus said was favorable study results.
*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.